All material subject to strictly enforced copyright laws. © 2022 IFLR is part of the Euromoney Institutional Investor PLC group.

Corporate governance quarterly: Sotheby's poison pill

Last month’s Delaware court ruling could provide boards with a significant tool to defend against activist hedge funds

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login